NBP (NBP) Stock Price & Analysis
NBP (NBP) rose 0.00% to USD 1.8 as of September 8, 2026 at 05:46 UTC, according to Nexqual real-time market data.
NBP last closed at USD 1.8; the session ranged USD 1.77–1.82 on volume of 71,520 shares. Market capitalization is —, with a 52-week range of USD 1.46–6.79 (NGM). Source: Nexqual, September 8, 2026 at 05:46 UTC.
Key Statistics (as of September 8, 2026 at 05:46 UTC)
| Price | USD 1.8 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 1.8 |
| Open | USD 1.8 |
| Day Range | USD 1.77 – 1.82 |
| 52-Week Range | USD 1.46 – 6.79 |
| Volume | 71,520 shares |
| Market Cap | — |
| Exchange | NGM |
Technical Analysis (NBP)
Nexqual's technical model rates NBP "SELL" based on 0 bullish and 4 bearish signals across 128 daily candles, as of September 8, 2026 at 05:46 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 45.82 (neutral) |
| vs SMA50 | Below (USD 1.83) |
| MACD | 0 (negative) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ZLAB | Zai Lab Limited | USD 26.23 | ▼ 0.94% |
| ALXO | ALX Oncology Holdings Inc. | USD 2.01 | ▼ 3.37% |
| BNR | Burning Rock Biotech Limited | USD 11.99 | ▲ 31.04% |
| LEGN | Legend Biotech Corporation | USD 21.52 | ▼ 1.69% |
| ZNTL | Zentalis Pharmaceuticals, Inc. | USD 3.99 | ▲ 5.84% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 05:46 UTC. This page is informational and not investment advice.